Literature DB >> 12677427

History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan.

Shigaku Ikeda1, Sadao Imamura, Isao Hashimoto, Shinji Morioka, Masahiro Sakuma, Hideoki Ogawa.   

Abstract

We summarize the process of establishing and revising the diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan (including the results of a nationwide survey regarding these guidelines). We also summarize the content and present an evaluation of the utility of these guidelines. Due to the publication of these documents throughout the Japanese medical community, it appears that patients with pemphigus have recently begun to receive appropriate treatment, dramatically improving their quality of life and prognosis. Continuous examination of these criteria by means of follow-up studies of patients treated according to the guidelines is necessary to determine the long-term efficacy of treatment. To this end, it is hoped that these guidelines will be more extensively disseminated among the medical community.

Entities:  

Mesh:

Year:  2003        PMID: 12677427     DOI: 10.1007/s00403-002-0367-2

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  10 in total

1.  World Workshop of Oral Medicine VII: A systematic review of immunobiologic therapy for oral manifestations of pemphigoid and pemphigus.

Authors:  Jacqueline W Mays; Barbara P Carey; Rachael Posey; Luiz Alcino Gueiros; Katherine France; Jane Setterfield; Sook Bin Woo; Thomas P Sollecito; Donna Culton; Aimee S Payne; Martin S Greenberg; Scott De Rossi
Journal:  Oral Dis       Date:  2019-06       Impact factor: 3.511

Review 2.  Quality of life in patients with bullous dermatoses.

Authors:  Deshan F Sebaratnam; James R McMillan; Victoria P Werth; Dédée F Murrell
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 3.  Severity score indexes for blistering diseases.

Authors:  Benjamin S Daniel; Michael Hertl; Victoria P Werth; Rüdiger Eming; Dédée F Murrell
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

4.  Assessing the autoantibody levels in relation to disease severity and therapy response in pemphigus patients.

Authors:  Deniz Aksu; Yavuz Peksari; Ibrahim Etem Arica; Erbak Gurgey
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

5.  Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.

Authors:  Xingli Zhou; Liangliang Cheng; Yiyi Wang; Hui Gou; Ke Ju; TianJiao Lan; Tongying Zhan; GaoJie Li; Yuanxia Gu; Yeting Sun; Yan Xu; Yukun Sun; Yanhong Zhou; Wei Li
Journal:  J Dermatol       Date:  2021-12-05       Impact factor: 3.468

6.  Successful treatment of pemphigus vulgaris with the extensive mucocutaneous lesions in an elderly patient.

Authors:  Mohsen Masjedi; Ali Asilian; Zabihollah Shahmoradi; Parvin Rajabi Dehnavi; Bahareh Abtahi Naeini
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

7.  Pemphigus vulgaris and infections: a retrospective study on 155 patients.

Authors:  Nafiseh Esmaili; Hossein Mortazavi; Pedram Noormohammadpour; Majid Boreiri; Tahereh Soori; Iman Vasheghani Farahani; Mitra Mohit
Journal:  Autoimmune Dis       Date:  2013-06-13

8.  Pemphigus: use of the Japanese severity index in 56 Moroccan patients.

Authors:  Hakima Benchikhi; Samira Nani; Hanane Baybay; Said Amal; Fatim-Zahra Mernissi
Journal:  Pan Afr Med J       Date:  2013-11-14

9.  Anal involvement in pemphigus vularis.

Authors:  Somayeh Khezri; Hamid-Reza Mahmoudi; Seyedeh Nina Masoom; Maryam Daneshpazhooh; Kamran Balighi; S Hamed Hosseini; Cheyda Chams-Davatchi
Journal:  Autoimmune Dis       Date:  2013-11-05

10.  Regulatory effects of Nr4a2 on Th2 cells from patients with pemphigus vulgaris.

Authors:  Jianbo Chen; Yao Zhang; Yunsheng Liang; Ming Zhao; Hai Long; Rong Xiao; Haijing Wu; Jieyue Liao; Shuaihantian Luo; Guiying Zhang; Qianjin Lu
Journal:  Oncotarget       Date:  2018-02-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.